Search Cancer Clinical Trials

Mass General Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
8 results
  • Sarcoma, Thyroid Cancer, Ovarian Cancer, Lung Cancer, Pancreatic Cancer, Kidney Cancer, Head and Neck Cancer, Breast Cancer, Liver Cancer

23-301          Phase I

A First-in-Human, Open-label, Multicenter, Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PYX-201 in Participants with Advanced Solid Tumors

  • Liver Cancer

24-265          Phase I

A Multicenter, Open-label, First-in-Human Study of TYRA-200 in Advanced Intrahepatic Cholangiocarcinoma and Other Solid Tumors with Activating FGFR2 Gene Alterations (SURF-201)

  • Endometrial Cancer, Esophageal Cancer, Gastric (Stomach) Cancer, Liver Cancer, Pancreatic Cancer, Sarcoma, Bladder Cancer

20-544          Phase II

A Phase 1/2 Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of PC14586 in Patients with Advanced Solid Tumors Harboring a p53 Y220C Mutation

  • Liver Cancer, Gallbladder and Bile Duct Cancers

21-725          Phase I

A Phase Ia/Ib Study of the Combination of the FGFR inhibitor Pemigatinib and the EGFR inhibitor Afatinib in Advanced Refractory Advanced Solid Tumors

  • Lung Cancer, Melanoma, Liver Cancer, Head and Neck Cancer, Endometrial Cancer, Colorectal Cancer, Bladder Cancer

24-203          Phase I

An Open-Label Study of GV20-0251 in Patients with Advanced and/or Refractory Solid Tumor Malignancies

  • Liver Cancer

17-733          Phase III

NRG-GI003: A Phase III Randomized Trial of Protons Versus Photons for Hepatocellular Carcinoma

  • Liver Cancer

23-394          Phase III

Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen

  • Liver Cancer

21-286          Phase I

Phase IB Study of Atezolizumab and Bevacizumab with SBRT for Unresectable Hepatocellular Carcinoma

Showing 1 - 10 of 8 results